News

Gradiant’s Innovative ForeverGone Technology Making Waves

Gradiant’s Innovative ForeverGone Technology Making Waves

Gradiant’s Contribution to Water Safety

Gradiant has established itself as a frontrunner in the realm of advanced water and wastewater treatment systems. Their cutting-edge technology, known as ForeverGone, is making headlines and has recently earned recognition on TIME’s Best Inventions of 2024.

Transforming PFAS Removal

The ForeverGone solution effectively addresses a significant environmental challenge: the removal and destruction of per- and polyfluoroalkyl substances (PFAS), commonly referred to as "forever chemicals." These substances have been increasingly found in water supplies and have raised serious health concerns, being linked to conditions such as cancer and developmental disorders.

Understanding the Impact of PFAS

PFAS are notoriously difficult to eliminate, which is why Gradiant's technology plays such an essential role. ForeverGone is an all-in-one solution that operates on-site, thereby reducing the risk of contaminating the environment with toxic runoff. This innovative method ensures cleaner water for communities and ecosystems alike.

Acknowledging Innovation

TIME acknowledges 200 groundbreaking inventions each year. The selection criteria include originality, efficacy, and impact, which are qualities that Gradiant’s ForeverGone technology possesses in abundance. Prakash Govindan, the COO of Gradiant, noted, “ForeverGone is different from anything in the marketplace – it completely solves the challenge of PFAS contamination.” This recognition underscores the technology's significance in the fight against environmental hazards.

How ForeverGone Works

The mechanics of ForeverGone involve a unique combination of Micro-Foam Fractionation and a Destruction Engine. This integration allows for the concentration of PFAS into a micro-foam that is then effectively destroyed via electro-oxidation. The outcome is water quality that meets or surpasses the latest US EPA drinking water standards.

Broad Industry Applications

Gradiant is expanding ForeverGone's applications across multiple industries including semiconductors, food processing, and even mining operations. By making PFAS remediation available to a wide range of sectors, Gradiant is paving the way for safer water management globally.

Community Engagement and Testing

Gradiant recognizes the importance of real-world application and has initiated a free testing program. This allows organizations to evaluate ForeverGone’s effectiveness in treating diverse contaminated water types. For those interested in exploring this technology further, Gradiant invites inquiries on its website.

About Gradiant

Gradiant prides itself on being a transformative force in the water industry. With its beginnings at MIT, the company has since grown to encompass over 1,000 employees and offers comprehensive solutions tailored for essential sectors like pharmaceuticals and renewable energy. The mission is clear: to reduce water usage and waste while converting wastewater back into freshwater. Their commitment goes beyond mere treatment; it embraces the reclamation of valuable resources.

Frequently Asked Questions

What is ForeverGone technology?

ForeverGone technology is Gradiant's innovative method for removing and destroying PFAS contaminants from water on-site.

Why is PFAS a concern?

PFAS, or forever chemicals, can remain in the environment indefinitely and have been linked to several health issues, making their removal essential for public safety.

How does ForeverGone work?

It uses a combination of Micro-Foam Fractionation and electro-oxidation to eliminate PFAS from contaminated waters effectively.

In which industries can ForeverGone be utilized?

ForeverGone has applications across various sectors, including but not limited to semiconductors, food & beverage, and mining.

How can one engage with Gradiant for testing?

Organizations interested in exploring ForeverGone can reach out to Gradiant through their official website for free testing opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Angels on Call Sets Benchmark for Specialized Homecare

Updated Category News Views 13

Pioneering a New Standard in Homecare Take a gander at Angels on Call Homecare. They're not just another name in a crowded field; they've carved out a niche—specializing in elite care for Dementia and Parkinson's patients. You don't usually hear homecare and innovation in the same breath, do you? But these folks are setting a fresh benchmark. Independent feedback has...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 8

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Noé Hinojosa Jr. Honored for Leadership in Business

Updated Category News Views 2

From Bonds to Ballgames: Hinojosa's Impact Listen up, because this one’s more than just another accolade on a shelf. Noé Hinojosa Jr., a big gun over at TRB Securities, is getting the 2026 Hispanic Business Salute Award, and it's a doozy. Awarded by all the big wigs—UPS, NBC 5, Telemundo 39, and the Dallas Cowboys—this isn't a small pat on the back. It's a full-on...

Continue Reading
Endava Faces Securities Fraud Lawsuit: Investor Implications

Updated Category News Views 0

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
AI-Designed Antivirals: A Brave New World

Updated Category News Views 7

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

Updated Category News Views 15

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 0

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 5

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading

Top 5 Most Recently Viewed Articles

Blackline Safety Posts 27% Revenue Surge in Fiscal Year 2024

Updated Category News Views 434

Blackline Safety's Fiscal Year 2024 Financial Performance Blackline Safety Corp. (TSX: BLN) has made impressive strides in its financial outcomes for the recent fiscal year. The company reports a remarkable total revenue of $127.3 million for 2024, marking a significant 27% increase year-over-year. These results demonstrate the effectiveness of the company's strategic...

Continue Reading
Government Projects India's Economic Growth at 6.5% for FY25

Updated Category News Views 237

Economic Growth Projections for India in FY25 The Indian economy is set to grow at an estimated rate of 6.5% during the fiscal year 2024/25. This projection, provided by government officials, aligns closely with the lower end of a broader range set between 6.5% and 7%. This outlook is framed against a backdrop of global uncertainties that could impact domestic growth...

Continue Reading
Investors Urged to Act on NANO Nuclear Energy Fraud Claims

Updated Category News Views 75

Overview of NANO Nuclear Energy NANO Nuclear Energy Inc. has recently found itself in the news due to a securities fraud lawsuit filed against the company. This situation serves as a crucial reminder for investors to actively seek information about their rights and options for potential recovery. Lawsuit Details The case, referred to as Yang v. Nano Nuclear Energy, Inc.,...

Continue Reading
Westinghouse Air Brake Technologies: A Potential Rebound Ahead

Updated Category News Views 127

Understanding Westinghouse's Current Position Shares of Westinghouse Air Brake Technologies Corporation (WAB) recently faced significant declines following disappointing earnings reports. However, the stock now appears to be positioned for a possible rally. Oversold Conditions and Key Support Levels The latest performance indicates that shares have become oversold,...

Continue Reading
BrainStorm Announces New Date for First Quarter Financial Call

Updated Category News Views 261

BrainStorm Reschedules Q1 2025 Financial Results Release BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a pioneer in adult stem cell therapeutics for neurodegenerative diseases, recently announced an important update regarding its financial results. The company has moved the release date for its financial performance for the first quarter, which ended on March 31,...

Continue Reading